• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种43千道尔顿外膜蛋白与痢疾志贺菌对β-内酰胺类抗生素耐药性的关系。

Involvement of a 43-kilodalton outer membrane protein in beta-lactam resistance of Shigella dysenteriae.

作者信息

Kar A K, Ghosh A S, Chauhan K, Ahamed J, Basu J, Chakrabarti P, Kundu M

机构信息

Department of Chemistry, Bose Institute, Calcutta, India.

出版信息

Antimicrob Agents Chemother. 1997 Oct;41(10):2302-4. doi: 10.1128/AAC.41.10.2302.

DOI:10.1128/AAC.41.10.2302
PMID:9333070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC164115/
Abstract

A beta-lactam-sensitive strain (C152) of Shigella dysenteriae showed two major outer membrane proteins (OMPs) with M(r)s of 43,000 and 38,000, while the clinical isolate M2 lacked the 43,000-Mr OMP, which acted as a channel for beta-lactam antibiotics. Permeability of beta-lactams across the outer membrane (OM) of M2 was lower than that across the OM of C152. Mutants deficient in the 43-kDa OMP could be selected in vitro from strain C152 in the presence of cefoxitin. All beta-lactam-resistant strains were sensitive to imipenem.

摘要

一株对β-内酰胺敏感的痢疾志贺氏菌(C152)显示出两种主要的外膜蛋白(OMP),分子量分别为43,000和38,000,而临床分离株M2缺乏分子量为43,000的OMP,该蛋白作为β-内酰胺抗生素的通道。β-内酰胺穿过M2外膜(OM)的通透性低于穿过C152外膜的通透性。在头孢西丁存在的情况下,可从C152菌株体外筛选出缺乏43-kDa OMP的突变体。所有对β-内酰胺耐药的菌株对亚胺培南敏感。

相似文献

1
Involvement of a 43-kilodalton outer membrane protein in beta-lactam resistance of Shigella dysenteriae.一种43千道尔顿外膜蛋白与痢疾志贺菌对β-内酰胺类抗生素耐药性的关系。
Antimicrob Agents Chemother. 1997 Oct;41(10):2302-4. doi: 10.1128/AAC.41.10.2302.
2
Impaired imipenem uptake associated with alterations in outer membrane proteins and lipopolysaccharides in imipenem-resistant Shigella dysenteriae.
J Antimicrob Chemother. 1999 Feb;43(2):195-201. doi: 10.1093/jac/43.2.195.
3
Alterations in high molecular mass penicillin-binding protein 1 associated with beta-lactam resistance in Shigella dysenteriae.与痢疾志贺氏菌β-内酰胺耐药性相关的高分子量青霉素结合蛋白1的改变。
Biochem Biophys Res Commun. 1998 Jul 30;248(3):669-72. doi: 10.1006/bbrc.1998.9042.
4
Differential expression of ompC and ompF in multidrug-resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aegle marmelos, altering its susceptibility toward beta-lactam antibiotics.枸橼酸苦木水提取物对多重耐药痢疾志贺菌和福氏志贺菌中ompC和ompF的差异表达,改变其对β-内酰胺类抗生素的敏感性。
Diagn Microbiol Infect Dis. 2008 Jul;61(3):321-8. doi: 10.1016/j.diagmicrobio.2008.02.006. Epub 2008 Mar 21.
5
Beta-lactamases and outer membrane investigations in beta-lactam-resistant Comamonas acidovorans strains.耐β-内酰胺类嗜酸丛毛单胞菌菌株中的β-内酰胺酶和外膜研究
Int J Antimicrob Agents. 1999 Jun;12(1):27-31. doi: 10.1016/s0924-8579(98)00095-8.
6
Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay.铜绿假单胞菌对青霉烯类抗生素表现出高度的固有耐药性:青霉烯类耐药机制及其相互作用。
Antimicrob Agents Chemother. 2001 Jul;45(7):1964-71. doi: 10.1128/AAC.45.7.1964-1971.2001.
7
Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams.奇异变形杆菌对亚胺培南或其他β-内酰胺类抗生素耐药的突变体对碳青霉烯类抗生素的通透性。
J Antimicrob Chemother. 1997 Sep;40(3):365-70. doi: 10.1093/jac/40.3.365.
8
Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.耐亚胺培南铜绿假单胞菌突变体对低分子量β-内酰胺抗生素敏感性降低:外膜蛋白D2在其扩散中的作用
J Antimicrob Chemother. 1990 Feb;25(2):191-8. doi: 10.1093/jac/25.2.191.
9
Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.
J Antimicrob Chemother. 1991 Dec;28(6):791-800. doi: 10.1093/jac/28.6.791.
10
Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.β-内酰胺酶和外膜蛋白在阴沟肠杆菌多重β-内酰胺耐药中的作用
Antimicrob Agents Chemother. 1985 Apr;27(4):455-9. doi: 10.1128/AAC.27.4.455.

引用本文的文献

1
Study of Antimicrobial Resistance (AMR) in spp. in India.印度某菌属的抗菌药物耐药性(AMR)研究。 (注:原文中“ spp.”表述有误,可能是“species”等词的错误形式,根据语境推测这里应该是指某个具体菌属,但仅从给定原文难以准确明确具体所指菌属,故按照大致意思翻译为“某菌属” )
Recent Adv Antiinfect Drug Discov. 2024;19(3):182-196. doi: 10.2174/0127724344268156231129095108.
2
Prevalence of Antibiotic-Resistant spp. in Bangladesh: A Systematic Review and Meta-Analysis of 44,519 Samples.孟加拉国抗生素耐药菌的流行情况:对44519份样本的系统评价和荟萃分析
Antibiotics (Basel). 2023 Apr 26;12(5):817. doi: 10.3390/antibiotics12050817.
3
Toward a Vaccine: Opportunities and Challenges to Fight an Antimicrobial-Resistant Pathogen.迈向疫苗:应对抗微生物药物耐药性病原体的机遇与挑战。
Int J Mol Sci. 2023 Feb 28;24(5):4649. doi: 10.3390/ijms24054649.
4
Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh.志贺菌病中的抗菌药物耐药性:孟加拉国 20 多年来城乡儿童的监测研究。
PLoS One. 2022 Nov 21;17(11):e0277574. doi: 10.1371/journal.pone.0277574. eCollection 2022.
5
: Antibiotic-Resistance Mechanisms And New Horizons For Treatment.抗生素耐药机制与治疗新视野
Infect Drug Resist. 2019 Oct 7;12:3137-3167. doi: 10.2147/IDR.S219755. eCollection 2019.
6
Beta-lactam resistance and Enterobacteriaceae, United States.美国的β-内酰胺耐药性与肠杆菌科细菌
Emerg Infect Dis. 2005 Sep;11(9):1464-6. doi: 10.3201/eid1109.050182.

本文引用的文献

1
Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes.产β-内酰胺类抗生素耐药阴沟肠杆菌外膜孔蛋白改变的发生率
Antimicrob Agents Chemother. 1996 Dec;40(12):2854-8. doi: 10.1128/AAC.40.12.2854.
2
In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.体内筛选肺炎克雷伯菌孔蛋白缺陷型突变体,其对头孢西丁和广谱头孢菌素的耐药性增强。
Antimicrob Agents Chemother. 1996 Feb;40(2):342-8. doi: 10.1128/AAC.40.2.342.
3
Multidrug efflux pumps of gram-negative bacteria.革兰氏阴性菌的多药外排泵
J Bacteriol. 1996 Oct;178(20):5853-9. doi: 10.1128/jb.178.20.5853-5859.1996.
4
beta-Lactamases in laboratory and clinical resistance.实验室及临床耐药中的β-内酰胺酶
Clin Microbiol Rev. 1995 Oct;8(4):557-84. doi: 10.1128/CMR.8.4.557.
5
Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.肺炎克雷伯菌对头孢哌酮-舒巴坦的耐药性:两种不同耐药机制共存导致耐药性增强的证据。
Antimicrob Agents Chemother. 1993 May;37(5):1061-4. doi: 10.1128/AAC.37.5.1061.
6
Resistance to antibiotics mediated by target alterations.由靶点改变介导的抗生素耐药性。
Science. 1994 Apr 15;264(5157):388-93. doi: 10.1126/science.8153626.
7
Prevention of drug access to bacterial targets: permeability barriers and active efflux.防止药物作用于细菌靶点:通透性屏障与主动外排
Science. 1994 Apr 15;264(5157):382-8. doi: 10.1126/science.8153625.
8
A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding.肺炎克雷伯菌的一种孔蛋白:序列同源性、三维模型及补体结合
Infect Immun. 1995 Mar;63(3):903-10. doi: 10.1128/iai.63.3.903-910.1995.
9
Antimicrobial resistance: prognosis for public health.
Trends Microbiol. 1994 Oct;2(10):422-5. doi: 10.1016/0966-842x(94)90623-8.
10
Characterization of a 38 kDa penicillin-binding protein and its possible involvement in maintaining stationary-phase cells of Shigella dysenteriae.
Microbiology (Reading). 1994 Nov;140 ( Pt 11):3177-82. doi: 10.1099/13500872-140-11-3177.